Well he did bring Bucillamine to the company and get a phase II trial done which helped us get our fast tracked phase 3 trial. He left 6 million in debt, not great but not the end of the world either imo.
That right there is probably the reason we are remaining under water. That partnership is not what the doctor ordered. Really looking forward to the letter to shareholders on that one. We deserve an explanation. Partnering with a company with no money is utterly ridiculous, unless there is something I am missing. Is there? Please?
News 
Market Data 
Discover 
AI
